News

Zacks Investment Research on MSN5h

Novo Nordisk Rises 6% So Far in August: How to Play the Stock

Novo Nordisk NVO faced a significant setback in July after sharply reducing its 2025 outlook for both sales and operating ...

The Zacks Analyst Blog Highlights Pfizer, Novo Nordisk and Eli Lilly

Pfizer beats Q2 estimates with rising oncology sales, new drug launches, and strong Seagen-driven portfolio growth.

Novo Nordisk: The Market Has Lost Its Mind

Novo Nordisk continues to deliver double-digit revenue and profit growth, driven by both its diabetes and obesity drug ...
sharewise9d

Will These 5 Pharma, Biotech Bigwigs Surpass Q2 Earnings Forecasts?

The second-quarter earnings season for the drug and biotech sector accelerated last week and will be in full swing this week, ...

Novo Nordisk: Q2 Earnings Snapshot

BAGSVAERD, Denmark (AP) — BAGSVAERD, Denmark (AP) — Novo Nordisk A/S (NVO) on Wednesday reported second-quarter profit of $4.03 billion. On a per-share basis, the Bagsvaerd, Denmark-based company said ...

Novo Nordisk Stock Hits New 52-Week Low Amid Profit Warning: What Investors Need To Know

Shares of Novo Nordisk are trading lower Wednesday morning. The stock is extending a dramatic sell-off from Tuesday's session.